{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:58:40Z","timestamp":1777316320956,"version":"3.51.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.2146\/ajhp150072","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T17:13:08Z","timestamp":1446743588000},"page":"1956-1959","source":"Crossref","is-referenced-by-count":8,"title":["Acetylcysteine for treatment of autism spectrum disorder symptoms"],"prefix":"10.1093","volume":"72","author":[{"given":"Danielle","family":"Stutzman","sequence":"first","affiliation":[{"name":"University of Southern California (USC) School of Pharmacy, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Dopheide","sequence":"additional","affiliation":[{"name":"Psychiatry and the Behavioral Sciences, USC School of Pharmacy and Keck School of Medicine, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008412468200_b1-0721956","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuro-psychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t2019041008412468200_b2-0721956","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b3-0721956","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/cap.2013.0137","article-title":"N-acetylcysteine as treatment for self-injurious behavior in a child with autism","volume":"24","author":"Marler","year":"2014","journal-title":"J Child Adolesc Psychopharm"},{"key":"key\n\t\t\t\t2019041008412468200_b4-0721956","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"key\n\t\t\t\t2019041008412468200_b5-0721956","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-244X-13-196","article-title":"A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders","volume":"13","author":"Ghanizadeh","year":"2013","journal-title":"BMC Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b6-0721956","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"key\n\t\t\t\t2019041008412468200_b7-0721956","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chc.2013.03.002","article-title":"Autism\u2014biomedical complementary treatment approaches","volume":"22","author":"Hendren","year":"2013","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"key\n\t\t\t\t2019041008412468200_b8-0721956","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaac.2013.10.013","article-title":"Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder","volume":"53","author":"Volkmar","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b9-0721956","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pbb.2011.02.003","article-title":"Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders","volume":"100","author":"Carlson","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"key\n\t\t\t\t2019041008412468200_b10-0721956","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b11-0721956","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2008.05.001","article-title":"Glutathione: a novel treatment target in psychiatry","volume":"29","author":"Berk","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t2019041008412468200_b12-0721956","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/15622970903144004","article-title":"Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia","volume":"10","author":"Bulut","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b13-0721956","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psycho-pharmacology (Berl)"},{"key":"key\n\t\t\t\t2019041008412468200_b14-0721956","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N- acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am J Addict"},{"key":"key\n\t\t\t\t2019041008412468200_b15-0721956","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chc.2013.07.004","article-title":"Psychiatric hospital treatment of children with autism and serious behavioral disturbance","volume":"23","author":"Siegel","year":"2014","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"key\n\t\t\t\t2019041008412468200_b16-0721956","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041008412468200_b17-0721956","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00213-013-3068-y","article-title":"Atypical anti-psychotics in the treatment of children and adolescents with pervasive developmental disorders","volume":"231","author":"Politte","year":"2014","journal-title":"Psychopharmacol-ogy (Berl)"},{"key":"key\n\t\t\t\t2019041008412468200_b18-0721956","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chc.2008.06.003","article-title":"Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders","volume":"17","author":"Soorya","year":"2008","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"key\n\t\t\t\t2019041008412468200_b19-0721956","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t2019041008412468200_b20-0721956","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1542\/peds.2011-2158","article-title":"Antipsychotics for children and young adults: a comparative effectiveness review","volume":"129","author":"Seida","year":"2012","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041008412468200_b21-0721956","volume-title":"Acetylcysteine solution package insert","year":"2004"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/22\/1956\/28318644\/ajhp1956.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T08:45:08Z","timestamp":1567327508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/22\/1956\/5111751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,15]]},"references-count":21,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150072","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,15]]}}}